Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Patents
Life Sciences Industry Reaches Crossroad Say Noted Pillsbury Attorneys
April 5th, 2008
Even as investors maintain their strong interest in the life sciences sector, industry stakeholders are facing tough decisions, according to Pillsbury attorneys. "Despite the current credit crunch in the U.S., life science organizations spanning biotechnology, pharmaceuticals and medical devices continue to enjoy relatively easy access to capital and growing markets compared to other areas of the economy," said San Diego partner John Wetherell, co-chair of Pillsbury's National Life Sciences Practice Team. "But concerns over where to hedge R&D bets, globalization's advantages and pitfalls, pivotal intellectual property concerns and shifting oversight and regulations in...
Source: Law & Health Weekly (2008-04-05)
|
